QLT Inc - Premium Company Profile
http://www.companiesandmarkets.com/Summary-Company-Profile/qlt-inc-premium-company-profile-41238.asp
- Market - Healthcare and Medical
- Published Date - 14/01/2008
- Report Type - Company Profile
- Country - Global
- Number of Pages - 55
Report Summary
Introduction
QLT was originally focused on discovering, developing and commercializing innovative therapies in the fields of ophthalmology and dermatology. In 2006, the company changed its focus to purely research and development by selling its manufacturing facility to Tolmar Pharmaceuticals.Scope
Contains corporate strategy, value chain presence and SWOT AnalysisProvides detailed business description, segment analysis, 5-year financial trends, key products and key competitorsIncludes information on suppliers/ partners, shareholding structure and key employees with biographiesHighlights
QLT has two marketed products: Visudyne for the treatment of wet age-related macular degeneration (AMD), pathologic myopia and presumed ocular histoplasmosis and Eligard for the palliative treatment of advanced prostate cancer.QLT derives its revenues form of product sales (net product revenue and royalties), contract research and development, and licensing and milestones. The company enters into commercial license agreements with pharmaceutical and biotechnology companies to market its products.The company's total revenues increased at a CAGR of 11.9% during 2002-2006, from $110.5 million to $175.1 million. This represents an absolute total growth of +$64.6 million for total revenues. The company's biggest contributor to revenue growth during 2002-2006 was product sales of Visudyne and Eligard.Reasons to Purchase
Access all the important information and analysis on the company in a single reportUnderstand company's strengths, weaknesses, opportunities and threats along with business strategy and value chainGain access to company's adjusted five year financial data along with key ratios and market capitalization
Table of Contents
TABLE OF CONTENTS
Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 8
Locations and Subsidiaries 12
Company Financials 13
Stock Market Performance 13
P&L 16
Balance Sheet 19
Cash Flow 19
Business Segment Performance 20
Geographic Segment Performance 21
Products & Services 22
Marketed Products 22
Pipeline Products 24
Historical Product Sales 26
Competitors and Strategic Business Relationships 28
Key Competitors 28
Key Clients 29
Shareholding Structure 31
Strategy 32
Company View 32
Corporate Strategy 35
SWOT Analysis 37
Overview 37
Strengths 38
Weaknesses 39
Opportunities 40
Threats 41
Value Chain Analysis 43
Overview 43
Discovery and Product Development 44
Key Employees 45
List of Key Employees 45
Key Employee Biographies 46
Financial and Operational Overview 53
Financial and Operational Overview 53
APPENDIX 55
Ask the analyst 55
Datamonitor consulting 55
Disclaimer 55
TABLE OF FIGURES
Figure 1: QLT - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 17
Figure 2: QLT - Key Strategic Revenues, 2002-2006 ($ Mn) 27
TABLE OF TABLES
Table 1: QLT - Key Facts 6
Table 2: QLT – Other Locations and Subsidiaries 12
Table 3: QLT - Year-End Share Price and Market Capitalization, 2002-2006 ($) 13
Table 4: QLT - Key Events Impacting Share Price Performance 14
Table 5: QLT - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 16
Table 6: QLT - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 18
Table 7: QLT - Balance Sheet, 2002-2006 ($ Mn) 19
Table 8: QLT - Cash Flow, 2002-2006 ($ Mn) 19
Table 9: QLT - Revenue Breakdown by Division, 2002-2006 ($ Mn) 20
Table 10: QLT - Geographic Breakdown, 2002-2006 ($ Mn) 21
Table 11: QLT - Marketed Products 22
Table 12: QLT - In-house Pipeline Products 24
Table 13: QLT - Historical Product Sales, 2002-2006 ($ Mn) 26
Table 14: QLT - Key Competitors 29
Table 15: QLT - Key Clients 30
Table 16: QLT - Key Shareholders 31
Table 17: QLT - SWOT Analysis Summary 37
Table 18: QLT - Value Chain Analysis 43
Table 19: QLT - Key Employees 45
Table 20: QLT - Financial and Operational Overview 53